Brexanolone Lifting Outcomes Of Moms

Summary

The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine: If LPCN 1154A reduces depressive symptoms in subjects with severe PPD How well LPCN 1154A is tolerated and what side effects it may cause

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Depression, Postpartum
• Postpartum Depression (PPD)
• Post-partum Depression
• Postnatal Depression
• Post-Natal Depression
• Peripartum Depression

Eligibility basics and study details

Study type

Interventional

Phase

Phase 3

Ages

15 to 45 years

Sex

Female

Healthy volunteers

Not accepted

Sponsor

Lipocine Inc.

Last updated on ClinicalTrials.gov

September 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites